We read with interest the COVID-19 Forecasting Team's description of the variation in COVID-19 infection–fatality ratio,1 confirming that differences in COVID-19 mortality between geographies are largely explained by the age structures of their populations. However, we fear that the lower than anticipated burden of severe COVID-19 in most of sub-Saharan Africa gets lost in estimations from models based on data from the few African countries that have reliable excess mortality data but are not representative of sub-Saharan Africa. Moreover, country-level estimates of COVID-19 infection–fatality ratio hide the observation that COVID-19 mortality in sub-Saharan Africa is highly concentrated in sections of the population with a more western lifestyle—usually wealthier individuals in urban centres.2 Such disparity is obvious for most people living in sub-Saharan Africa, where COVID-19 is sometimes popularly called “VIP disease” or “rich person disease”.
We suspect that, besides a higher prevalence of obesity, hypertension, and diabetes among wealthier people, immunological factors are at play. Several studies associate chronic parasitic infection (more prevalent among people living in poverty with a less westernised lifestyle) with less severe clinical presentation of COVID-19.3, 4 Such findings are consistent with the importance of a diverse microbiome and chronic immune stimulation in maintaining a well trained immune system that is less likely to cause hyperinflammation, which is critical in severe COVID-19.
Although unexplored, the notion that the better-off might fare worse is not unique to COVID-19 in sub-Saharan Africa. It is also consistently documented that autoimmune diseases, more prevalent in high-income countries, share a common pathway with severe COVID-19, linking reduced microbiome diversity to hyperinflammation, popularised as the hygiene hypothesis.5 Similar links have been documented in HIV serosurveys in the 2000s in sub-Saharan Africa, in which the better-off had higher risk of HIV infection.6
It is vital to deepen our understanding of microbiome diversity and linked immunological factors in the severity of COVID-19, and account for this when modelling COVID-19 infection–fatality ratios.
Acknowledgments
We declare no competing interests.
References
- 1.COVID-19 Forecasting Team Variation in the COVID-19 infection–fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis. Lancet. 2022;399:1469–1488. doi: 10.1016/S0140-6736(21)02867-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.De Weerdt J, Van Damme W. Health, wealth and the double paradox of COVID-19 mortality in low-income countries. SSRN. 2021 doi: 10.2139/ssrn.3793427. published online March 2. (preprint). [DOI] [Google Scholar]
- 3.Achan J, Serwanga A, Wanzira H, et al. Current malaria infection, previous malaria exposure, and clinical profiles and outcomes of COVID-19 in a setting of high malaria transmission: an exploratory cohort study in Uganda. Lancet Microbe. 2022;3:e62–e71. doi: 10.1016/S2666-5247(21)00240-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Wolday D, Tasew G, Amogne W, et al. Interrogating the impact of intestinal parasite-microbiome on pathogenesis of COVID-19 in sub-Saharan Africa. Front Microbiol. 2021;12 doi: 10.3389/fmicb.2021.614522. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Finlay BB, Amato KR, Azad M, et al. The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome. Proc Natl Acad Sci USA. 2021;118 doi: 10.1073/pnas.2010217118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Piot P, Greener R, Russell S. Squaring the circle: AIDS, poverty, and human development. PLoS Med. 2007;4:1571–1575. doi: 10.1371/journal.pmed.0040314. [DOI] [PMC free article] [PubMed] [Google Scholar]